Bellco Capital LLC is a California-based direct investment firm founded by Rebecka Belldegrun, M.D., and Arie Belldegrun, M.D. The firm focuses on deploying capital to create and support companies with ambitions of exponential transformation across diverse sectors, including life sciences, real estate, consumer products, and media. Bellco Capital typically invests in Series A and Series B rounds, with occasional seed and private equity investments.
Notable portfolio companies include Allogene Therapeutics, ByHeart, Dewpoint Therapeutics, Hubble Contacts, IconOVir Bio, Kite Pharma, and Kronos Bio. The firm is led by key partners with significant industry expertise, particularly in life sciences. Bellco Capital emphasizes building strong relationships with its portfolio companies and offers unique value-add services to foster their growth and success.
Bellco Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
